Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

In a systematic review, the incidence of gastrointestinal-related adverse events associated with the use of biologic therapies for psoriasis was 8.7%.

The policy of billing for secure messages changes patient expectations and can impact the patient-physician relationship.

Telogen effluvium prevalence has significantly increased following the COVID-19 pandemic, but no association was observed for COVID-19 vaccines.

During the COVID-19 public health emergency period, excess mortality occurred in all racial and ethnic groups, but disparities were observed.

Food allergy-related distress is common and varies across countries, according to study findings published in the October issue of Allergy.

Vaccination for influenza, SARS-CoV-2, and respiratory syncytial virus is less likely with an increasing social vulnerability index and Black race.

COVID-19 vaccination is associated with a reduced risk for most CV events, but with slightly increased risks for extrasystoles and transient ischemic attack, as well as myocarditis and pericarditis ...

AI-generated responses to patient portal messages may improve workflow for nurses but not for other health care workers, a new study suggests.

The RSV vaccine Abrysvo was highly effective against hospital and ED encounters in a large cohort of older adults with comorbidities and immunocompromising conditions.

Research suggests that prior authorization has negative effects on patients with cancer and oncology providers.

The FDA has approved Imuldosa, a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.